Eurofins Scientific - 1997 - 2001 - Expanding the technology portfolio
The focus for Eurofins during this time was to buy the very best labs with unique technologies and know how with the potential for global recognition. Additionally the Group expanded to eight new countries and grew to include over 50 laboratory sites.
Leading positions were built up in core markets (Food, Pharma and Environment) and also key segments such as genomic information and contaminants testing. This in turn enabled the group access to new, top-tier clients in the pharma and retailing sectors.
This was funded firstly with the IPO in Paris in 1997 and then the secondary listing in Frankfurt in 2000.